Last Updated:
Name Designation Appointment Date Status
Vijay Khurana

Appointed as Director since October 2020

Director 16-Oct-2020 Current
Name Designation Appointment Date Status
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Ferdinando Borgese

Appointed as Managing Director since July 2017

Managing Director 07-Jul-2017 Current
Avninder Singh

Appointed as Director since December 2013

Director 06-Dec-2013 Current

People Timeline

Explore the timeline of key personnel in Kedrion Biopharma India Private Limited's leadership journey.

Loading...
Contact Details
  • Address House No. R-265C, Ground Floor Greater Kailash Part-I, New Delhi Delhi, 110048, India
  • Telephone Upgrade
  • Email Upgrade
Frequently Asked Questions
How can I contact Kedrion Biopharma India Private Limited?
You can contact Kedrion Biopharma India Private Limited through their registered address at House No. R-265C, Ground Floor Greater Kailash Part-I, New Delhi Delhi, 110048, India, or via their website at kedrion.com. Social media links are also provided where applicable.
Who are the current directors of Kedrion Biopharma India Private Limited?
The current directors of Kedrion Biopharma India Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • FERDINANDO BORGESE
  • VIJAY KHURANA
  • AVNINDER SINGH
How can I access past director details?
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available